| NCT02172976 |
Randomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant / Adjuvant FOLFIRINOX for Resectable Pancreas Carcinoma |
View |
| NCT02468076 |
Radiofrequency Ablation for Biliopancreatic Malignancy |
View |
| NCT01134276 |
Comparison Between Internal and External Preoperative Biliary Drainage in Periampullary Cancers |
View |
| NCT02560376 |
68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis |
View |
| NCT01392027 |
Biospecimens for Identification of Diseases of the Pancreas. |
View |
| NCT03311776 |
BIOmarkers in Patients With Pancreatic Cancer (ȫIOPAC") |
View |
| NCT01794676 |
Genetic Evaluation of Families With Endocrine Cancers |
View |
| NCT05014776 |
Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer |
View |
| NCT03432676 |
Epacadostat and Pembrolizumab in Treating Participants With Advanced Pancreatic Cancer |
View |
| NCT03960060 |
A Study of CCT301-59 CAR T Therapy in Adult Subjects With Recurrent or Refractory Solid Tumors |
View |
| NCT06022276 |
Nimotuzumab for EGFR-amplified Advanced Pan Solid Tumors |
View |
| NCT06436976 |
The Effect of Probiotics ATG-F4 in Cancer Patients |
View |
| NCT00057876 |
Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer |
View |
| NCT02230176 |
Antitumor Efficacy of Peptide Receptor Radionuclide Therapy With 177Lutetium -Octreotate Randomized vs Sunitinib in Unresectable Progressive Well-differentiated Neuroendocrine Pancreatic Tumor: First Randomized Phase II |
View |
| NCT04896073 |
Superenhancer Inhibitor Minnelide in Advanced Refractory Adenosquamous Carcinoma of the Pancreas (ASCP) |
View |
| NCT04353973 |
Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Predisposition in Metastatic Cancer Patients |
View |
| NCT03716531 |
Electron Beam Intraoperative Radiation Therapy Following Chemoradiation in Patients With Pancreatic Cancer With Vascular Involvement |
View |
| NCT03576131 |
GEN1029 (HexaBody®-DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors |
View |
| NCT01186731 |
Efficacy and Safety Study of LE-DT to Treat Locally Advanced or Metastatic Pancreatic Cancer |
View |
| NCT03114631 |
Dendritic Cell Immunotherapy for the Patients With Pancreatic Cancer |
View |
| NCT00197431 |
Pharmacokinetic and Pharmacodynamic Study of S-1 in Patients With Digestive Organ Cancer |
View |
| NCT03073473 |
Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers |
View |
| NCT04581473 |
Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection |
View |
| NCT06496373 |
Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer |
View |
| NCT03791073 |
New Biomarkers in Pancreatic Cancer Using EXPEL Concept |
View |
